Based on SEC filing data. A biotech corporation based in Washington, DC, this growth-stage company has raised $70.5 million in equity funding. The company operates in the biotechnology sector.
Get notified the moment REGENXBIO Inc. (RGNX) files a new round, hires execs, or shows traction signals.
Create free accountAbout this data
FlareSight surfaces funding data from SEC Form D filings within hours of submission. Browse our full startup funding database to find more recently funded companies.